Litton Mark James

EDGAR CIK 0001604834

Athira Pharma, Inc. - ATHA

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CEO Director
President and CEO
Direct Buys
0
$0
0 Shares
Direct Sells
2
($16,874)
-9,852 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/05/2024
09/05/2024
Sell
-5,032 @ $0.57
 ($2,848) 159,365 (-3.06%) Direct
01/05/2024
02/16/2024
Sell
-4,820 @ $2.91
 ($14,026) 144,397 (-3.23%) Direct